Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00014534

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arroyo Grande Community Hospital Arroyo Grande, California, United States
  • Rebecca and John Moores UCSD Cancer Center San Diego, California, United States
View all 285 locations
View Trial Details
Completed

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

NCT02144051

Conditions
Adnexal Diseases, Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor, Breast Diseases, +32 more
Locations
  • Research Site Sarasota, Florida, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Milwaukee, Wisconsin, United States
  • Research Site London, United Kingdom
View Trial Details
Completed

Docetaxel in Treating Patients With Solid Tumors

NCT00003565

Conditions
Bladder Cancer, Breast Cancer, Breast Diseases, +54 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View all 74 locations
View Trial Details
Completed

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

NCT00003623

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
View all 17 locations
View Trial Details
Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

NCT00003704

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +56 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
View all 18 locations
View Trial Details
Completed

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

NCT00948961

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +53 more
Locations
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer

NCT00645593

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Robert H. Lurie Comprehensive Cancer Center, Center of Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions